ACLA Press Releases

  • ACLA Update on COVID-19 Testing Capacity

    June 27, 2020
    WASHINGTON, D.C – Following a surge of new COVID-19 cases in the United States, ACLA President Julie Khani issued the following statement: “ACLA member laboratories have seen a steady increase in the volume of COVID-19 test orders. While our members are collectively performing hundreds of thousands of tests each day, the anticipated demand for COVID-19 testing over the coming weeks will likely exceed members’Continue Reading »...
  • ACLA Responds to New Tri-Agency Guidance, Calls on Federal Government to Address Newly-Created Coverage Gaps

    June 23, 2020
    WASHINGTON, D.C. – Following additional guidance released today from the Department of Labor, the Department of Treasury, and the Department of Health and Human Services regarding the coverage and payment requirements for testing in the Families First Coronavirus Response Act and the CARES Act, ACLA President Julie Khani released the following statement: “As leading government officials outlined in congressional testimony today, testing is aContinue Reading »...
  • Amid Growing Demand For Testing, Lawmakers Call On HHS To Designate Resources For Clinical Laboratories

    June 08, 2020
     In a bipartisan letter to Secretary Azar, 30 lawmakers urge HHS to designate funds to help clinical laboratories expand capacity WASHINGTON, D.C. – As clinical laboratories continue to work around the clock to expand access to high-quality testing across the country, a bipartisan group of lawmakers today urged Health and Human Services Secretary Alex Azar to direct funds from the Public Health and SocialContinue Reading »...
  • ACLA Statement on New Data Reporting Guidance

    June 04, 2020
    WASHINGTON, D.C. – As ACLA reviews the new data reporting guidance released today by the Department of Health and Human Services (HHS), ACLA President Julie Khani released the following statement:   “Information is power. This simple truth drives our mission and purpose as clinical laboratories, and it’s why, since the start of this public health emergency, ACLA members have made every effort to report theContinue Reading »...
  • ACLA Statement on Medicare Reimbursement Rate For Serologic Testing

    May 19, 2020
    WASHINGTON, D.C. – Following the release by the Centers for Medicare and Medicaid Services (CMS) of a reimbursement rate of $42.13 for the most commonly-performed COVID-19 serologic tests, ACLA President Julie Khani released the following statement: “We applaud CMS’ release of a Medicare reimbursement rate that will encourage a broad cross section of laboratories to rapidly scale up capacity for accurate and reliable serologicContinue Reading »...
  • ACLA Statement on HEROES Act

    May 12, 2020
    WASHINGTON, D.C. — Following the introduction of the ‘‘Health and Economic Recovery Omnibus Emergency Solutions (HEROES) Act” ACLA President Julie Khani issued the following statement: “ACLA is currently reviewing the HEROES Act. As noted in our letter to Secretary Azar last month, direct federal funding for laboratories performing COVID-19 testing is critical to achieve our nation’s testing goals. As labs across the country plan for the large capital expensesContinue Reading »...
  • ACLA Statement on Expanding Access to Testing

    May 11, 2020
    WASHINGTON, D.C. — Following the Trump Administration’s announcements today on expanding access to testing, ACLA President Julie Khani released the following statement:  “After scaling up to meet an unprecedented demand for testing, ACLA members have performed nearly five million tests for COVID-19. By expanding the availability of specimen collection materials, such as swabs and transport media, the actions announced by the White House today will help states takeContinue Reading »...
  • ACLA Statement on Support Necessary For Laboratories

    May 06, 2020
    WASHINGTON, D.C. — Following ongoing developments related to COVID-19 testing and response, ACLA President Julie Khani issued the following statement:  “Labs are not scaling back. We’re ramping up. ACLA members are investing in additional high-throughput testing platforms, retraining staff, and working to anticipate the supply challenges we’ll face down the road. During ACLA’s first meeting with the White House Coronavirus Task Force on March 4, weContinue Reading »...
  • ACLA Statement on FDA’s Revised Policy for Serologic Tests  

    May 04, 2020
    WASHINGTON, D.C. –  Following the revised policy on serologic testing announced today by the Food and Drug Administration, ACLA President Julie Khani issued the following statement: “ACLA is reviewing the latest announcement by the FDA. We commend the agency for its continued diligence in evaluating the available data regarding testing options and implementing policies that promote the public’s health. It is essential that patients and clinicians canContinue Reading »...
  • ACLA Statement on White House Meeting

    April 27, 2020
    WASHINGTON, D.C. – Following today’s meeting at the White House, ACLA President Julie Khani issued the following statement: “ACLA appreciated the opportunity to meet today with President Trump, Vice President Pence and other members of the White House Coronavirus Task Force. Representing the backbone of our nation’s testing response, ACLA members have now performed 3.2 million tests and remain focused on continuing to increaseContinue Reading »...